(5S)-N-(Methoxycarbonyl)-L-valyl-5-methyl-L-proline
CAS: 1335316-40-9
Rif. TR-M261343
1g | Fuori produzione | ||
5g | Fuori produzione | ||
10g | Fuori produzione |
Informazioni sul prodotto
- N-[2-(S)-[(Methoxycarbonyl)amino]-3-methylbutyryl]-(5S)-5-methyl-L-proline
- (2S,4S)-1-(tert-butoxycarbonyl)-4-(methoxyMethyl)pyrrolidine-2-carboxylic acid
- (2S,5S)-1-((S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-5-methylpyrrolidine-2-carboxylic acid
- (2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid
- <span class="text-smallcaps">L</smallcap>-Proline, N-(methoxycarbonyl)-<smallcap>L</span>-valyl-5-methyl-, (5S)-
- N-[2-(S)-[(Methoxycarbonyl)amino]-3-methylbutyryl]-(5S)-5-Methyl-<span class="text-smallcaps">L</span>-proline
- L-Proline, N-(methoxycarbonyl)-L-valyl-5-methyl-, (5S)-
- N-[2-(S)-[(Methoxycarbonyl)amino]-3-methylbutyryl]-(5S)-5-Methyl-L-proline
Applications (5S)-N-(Methoxycarbonyl)-L-valyl-5-methyl-L-proline is an antiviral agent and Velpatasvir (V116000) intermediate. Velpatasvir is a NS5A inhibitor in patients with hepatitis C (HCV) infection.
References Feld, J. J., et al.: N. Engl. J. Med. 373, 2599 (2015); Gane, E. J., et al.: Gastroenterol., 151, 448 (2016);